Fludarabine phosphate in chronic lymphoproliferative diseases. The French Group on CLL.

J L Binet

文献索引：Nouv. Rev. Fr. Hematol. 35(1) , 5-7, (1993)

全文：HTML全文

摘要

The review of Phase II trials in patients treated by Fludarabine phosphate (Fludara I.V) has been demonstrated to have unequivocal benefit for some patients with Chronic Lymphocytic Leukemia (CLL) non Hodgkin lymphoma and macroglobulinemia. Comparison of Fludara I.V with other treatment regimens is now studied in randomised protocols for B and C stages of CLL.